Compounds > ag-1549
Page last updated: 2024-10-21

ag-1549 and HIV Infections

ag-1549 has been researched along with HIV Infections in 4 studies

capravirine: a non-nucleoside reverse transcriptase inhibitor

HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pauwels, R1
Gewurz, BE1
Jacobs, M1
Proper, JA1
Dahl, TA1
Fujiwara, T1
Dezube, BJ1

Reviews

1 review available for ag-1549 and HIV Infections

ArticleYear
New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections.
    Current opinion in pharmacology, 2004, Volume: 4, Issue:5

    Topics: Anti-HIV Agents; Clinical Trials as Topic; Drug Resistance, Viral; HIV Infections; HIV Reverse Trans

2004

Trials

1 trial available for ag-1549 and HIV Infections

ArticleYear
Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: a phase 1 study.
    The Journal of infectious diseases, 2004, Dec-01, Volume: 190, Issue:11

    Topics: Administration, Oral; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Female; HIV Infections; HIV-1

2004

Other Studies

2 other studies available for ag-1549 and HIV Infections

ArticleYear
Capravirine trials stopped.
    AIDS patient care and STDs, 2001, Volume: 15, Issue:4

    Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Dogs; HIV Infections; Humans; Imidazoles; Sulfur

2001
New drugs in development.
    Project Inform perspective, 1998, Issue:25

    Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; CD4 Lymphocyte Count; Clinical Trials a

1998